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Abstract 
Introduction – People who inject drugs (PWID) are stigmatized by society. Over time people 
may begin to internalize the stigma about their group. This research examines how implicit and 
explicit internalized stigma among PWID relates to health care and treatment access, 
psychosocial functioning, and engagement in risky behaviors.  
Methods – PWID were recruited from a needle and syringe program (NSP) located in Sydney, 
Australia. Participants completed a survey examining explicit and implicit internalized stigma, 
risky behaviors (e.g., sharing injecting equipment, unprotected sex), health care and treatment 
access (e.g., comfort attending NSPs), and psychosocial functioning (e.g., mental health). 
Detailed demographic variables were also collected.  
Results – A total of 115 clients completed the measures. To the degree that participants had 
internalized the stigma about their group (measured explicitly), they felt less comfortable 
attending NSPs, had greater severity of dependence, and experienced more depressive symptoms. 
The implicit measure of internalized stigma was related to treatment engagement and needle 
sharing, although the direction of these effects was unexpected.  
Conclusions –This research highlights the importance of ongoing research into the implications 
of internalized stigma for PWID. Assessing both explicit and implicit internalized stigma appears 
to be beneficial as these are related to different health and behavioral outcomes. 
 
Keywords: internalized stigma; implicit associations; IAT; injecting drug use; risk behaviors  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
A long research tradition demonstrates that being stigmatized negatively impacts 
psychological health (e.g., self-esteem and emotional well-being; Bourguignon et al., 2006; 
Major et al., 2002, 2007) and physical health (Ahern et al., 2007; Hopwood et al., 2006; Schuster 
et al., 2005). Injecting drug use is a highly stigmatized behavior and people who inject drugs 
(PWID) receive harsh condemnation (Capitanio and Herek, 1999; Frable, 1993). PWID are 
stereotyped as dangerous, irresponsible, and weak (Conrad et al., 2006; Herek et al., 2003; Tindal 
et al., 2010). They are often perceived as people who steal to support their habit and pollute 
mainstream society with their chaotic behavior and drug related illnesses (Elliott and Chapman, 
2000). These negative views of PWID are not limited to the general public, as it is well 
documented that PWID also experience stigma and discrimination from health care workers (Day 
et al., 2003; Hopwood et al., 2006; von Hippel et al., 2008; Wilson et al., 2014).  
Over time, people from stigmatized groups can come to internalize the stigmatizing 
attitudes that others hold about them (Gilmore and Somerville, 1994). This self-stigma occurs 
when people internalize the stereotypes about their group and blame themselves for their illness 
(Corrigan et al., 2016). Most research on internalized stigma and health related outcomes has 
come from the mental health field where internalized stigma is related to lower self esteem, 
reduced confidence and hope, decreased likelihood of adhering to or completing treatment, and 
an increased severity of psychiatric symptoms (Corrigan & Watson, 2002; Corrigan et al., 2006; 
Livingston & Boyd, 2010; Watson et al., 2007). Similarly, for those living with HIV/AIDs 
greater internalized stigma is associated with poorer mental health (Lawless et al., 1996; Logie & 
Gadalla, 2009; Simbayi et al, 2007), less disclosure of their HIV status (Overstreet et al., 2013), 
and less social support (Lawless et al., 1996; Lee et al., 2002).  
Research on addiction self-stigma is growing, with outcomes mostly consistent with those 
found in the mental health field (for a notable exception see Luoma et al (2013) where higher 
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self-stigma was associated with longer stays in residential rehabilitation). Limited research has 
examined internalized stigma among PWID specifically, but the studies that do exist are 
consistent with research on other stigmatized groups. For example, internalized stigma was 
related to increased depression and lower self-esteem (Cama et al., 2016) and was associated with 
suboptimal use of pharmacies and needle exchange programs for access to sterile injecting 
equipment (Rivera et al., 2014). It seems feeling negative about your self is associated with less 
concern about health or causing themselves harm (Fraser and Treloar, 2006). 
The present research examines internalized stigma among PWID in Australia. Although 
Australia has a more progressive approach to illicit drug use than many countries, PWID continue 
to face stigma and discrimination (Treloar et al., 2015; Wilson et al, 2014). As a consequence, 
they may internalize societal stigma about themselves. This study extends previous research on 
internalized stigma and risky behaviors by examining risky behaviors beyond needle sharing, 
including multiple/binge drug use and sexual risk taking. We also examine the relationship 
between internalized stigma and psychosocial functioning (severity of dependence; mental 
health), and health care and treatment access (treatment engagement; comfort in attending needle 
and syringe programs [NSPs]).  
This research also examines implicit internalized stigma. Attitudes and beliefs have 
traditionally been measured via explicit measures, in which people are directly asked about their 
feelings. There has been an explosion of research on implicit measures, which allow for the 
assessment of attitudes and beliefs without the person being directly asked about them. A major 
advantage of implicit measures is they can reveal attitudes and beliefs of which people are 
unaware (Fazio & Olson, 2003), which is particularly relevant in this context because the link 
between addiction-related internalized stigma and identity may not be consciously accessible 
(i.e., the stigma is automatically activated and without introspection). Implicit measures may also 
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predict important behaviors that are not accounted for by people’s explicit self-reports. For 
example, implicit measures have been shown to predict reduction in panic symptoms among 
panic disorder clients in psychological treatment (Teachman et al., 2008), relationship break-up 
among romantic couples (Lee et al., 2010), and retention in residential rehabilitation (Wolff et al., 
2015) beyond the impact of explicit measures. Thus, in important real-world circumstances, 
implicit measures sometimes predict current and future behavior better than consciously 
expressed beliefs and attitudes do.  
The present research examines how implicit and explicit internalized stigma relates to 
health care and treatment access, psychosocial functioning, and risk behaviors among a sample of 
PWID. Based on previous research, it is predicted that PWID who have internalized the stigma 
will engage in more risk behaviors, have poorer mental health and psychosocial functioning, and 
be less engaged in treatment. We also explore whether differences emerge between implicit and 
explicit measures of internalized stigma. 
Method 
Sample and procedure 
Participants (who were currently injecting drugs and over 18 years) were recruited from a 
NSP located in Sydney from May 9
th
 to June 7
th
 2016. Staff informed eligible clients about the 
study on the three days per week that a research assistant was present. One hundred and fifteen 
clients (69 men; 45 women; 1 non-response) participated. The study took approximately 20 
minutes to complete, and consisted of a self-administered computer-based questionnaire and two 
single category implicit association tests (SC-IATs). Participants were reimbursed $20 for their 
time. Data were collected over a one-month period. The study received ethics approval from the 
Human Research Ethics Committee at the University of New South Wales, the University of 
Queensland, and the relevant local health district.  
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Measures 
The survey was pre-tested with three volunteers from a peer drug user organization who 
had a history of injecting. After pre-testing, slight wording changes were made to remove 
ambiguities and better reflect the vocabulary of PWID. 
Demographics. Participants answered questions assessing their age, gender, sexuality, 
drug treatment experiences, living arrangements, education, and income (See able 1).  
Injecting drug use. The survey assessed age at first injecting, injecting frequency over the 
past two weeks, drug of choice, and how many friends inject. 
Risk behavior. A range of risk behaviors was examined. Sharing was assessed by asking 
participants how often they used a needle and syringe after someone else. Participants were also 
asked whether they had binged on two or more drugs for an extended period of time, as the 
synergistic and additive effects of combining drugs increases the harms associated with drug use 
(Lee et al., 2012; Smit et al., 2002). Sexual risk practices were assessed with the question Have 
you engaged in unprotected penetrative (anal or vaginal) sex within the last 6 months?  
Health care and treatment access. Two areas of health care and treatment access were 
explored: treatment engagement and comfort in attending NSPs. Treatment engagement was 
assessed with the question “When were you last in drug treatment?” using 5-point scale ranging 
from currently on treatment to more than five years ago. Comfort in attending NSPs was 
assessed with the question “How comfortable are you in attending a NSP or other service to 
obtain needles and syringes?” using a 5-point scale ranging from very uncomfortable to very 
comfortable. 
Psychsocial functioning. Mental health was assessed with the Kessler Psychological 
Distress Scale (K10; Kessler and Mroczek, 1994), a ten-item scale measuring anxiety and 
depressive symptoms experienced in the last week (for example, During the last week, how often 
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did you feel nervous?). Items were scored on a 5-point scale ranging from none of the time to all 
of the time with higher scores representing greater distress, depression, and anxiety. Internal 
reliability in this study was found to be good (α = .92).  
The Severity of Dependence Scale (SDS; Gossop et al., 1995) is a five-item scale used to 
measure the degree of dependence, anxiety, and impaired control over use of illicit substances 
(for example, Over the past month, did you ever think your use of drugs was out of control?). 
Responses were provided on a 4-point scale ranging from never or almost never to always or 
almost always with higher scores indicating greater dependence. Internal reliability in this study 
was found to be good (α = .79).  
Attitudes towards PWID. Rivera et al (2014) used 5-items from Brener and von Hippel’s 
(2008) attitudes towards PWID scale to tap internalized stigma was included to explore 
differences between the two explicit internalized stigma scales. Sample items include I won't 
associate with known injecting drug users if I can help it and Injecting drug use is immoral. 
Participants indicated their agreement on a five-point scale ranging from strongly disagree to 
strongly agree, with higher scores signifying more negative attitudes towards PWID. The scale 
showed good internal reliability (α = .81). 
Explicit internalized stigma. Explicit internalized stigma was assessed using a 7-item 
measure (Cama et al., 2016), adapted from the Internalized Stigma of Mental Illness (ISMI) scale 
(Boyd et al., 2014). Sample items include Being an injecting drug user makes me feel dirty and I 
sometimes feel worthless because I inject drugs. Participants indicated their agreement on a five-
point scale ranging from strongly disagree to strongly agree, with higher scores signifying 
greater internalized stigma. The scale showed good internal reliability (α = .89).  
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SC-IAT.  The most well-known and widely used instrument to assess implicit attitudes is 
the Implicit Association Test (IAT: Greenwald et al., 1998). The IAT measures implicit 
associations by assessing response times in a computer-administered categorization task. A 
typical IAT involves a series of categorization tasks with multiple trials, wherein an individual is 
asked to categorize concepts as rapidly as possible. Because the IAT is based on comparisons 
between concepts, it can only measure the association of attributes of one concept relative to 
another (Greenwald and Farnham, 2000). With injecting drug use, however, there is no obvious 
contrasting category. As a consequence, the Single Category Implicit Association Task (SC-IAT) 
developed by Karpinski and Steinman (2006) was used, because it measures associations with a 
single category. As with the IAT, the SC-IAT uses response times to assess evaluation of a single 
concept.  
Two different SC-IATs were used in this study, one to assess positive/negative feelings 
towards drug use and one to assess implicit identification with drug use. By combining the two 
SC-IATSs, the instruments can assess participants’ internalized stigma. That is, participants who 
identify as a drug user while simultaneously indicating that drug users are bad are said to have 
internalized the stigma. One of the SC-IATs was adapted from an injecting drug use SC-IAT 
from Brener et al. (2007). In this SC-IAT, the participant first categorizes good words (good, 
excellent, great, wonderful) on one response key and bad words (bad, terrible, awful, horrible) on 
a different key. Intermixed with these categorizations, participants were also asked to identify 
words that are stereotypically associated with the concept of drug user (druggie, user, junkie, 
injector), using the same response key as is used for the good words. The categorization task was 
then reversed such that words stereotypically associated with drug users were responded to on the 
same key as bad words. The implicit attitude is inferred by the relative ease with which the words 
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stereotypically associated with drug users can be responded to on the good or bad response key 
(see Figure 1).  
In the other SC-IAT, participants first categorized Me words (I, me, mine, myself) along 
with these same stereotypic words regarding a Drug User (druggie, user, junkie, injector) on one 
response key and Not Me words (they, their, them, other) on a different key. Again, this pattern 
was then reversed with Not Me words being paired with Drug User on one key and Me words on 
a different key. To eliminate possible order effects, the order of the two SC-IATs was 
counterbalanced. 
SC-IAT scores were created for each participant following the procedures of Greenwald 
et al. (2003). Thus, the mean latency when me and drug user shared a response key was 
subtracted from the mean latency when not me and drug user shared a response key. This 
difference score was then divided by the standard deviation of all of the blended trials. As a result 
of this scoring procedure, higher scores on the SC-IAT represented a stronger association 
between self and drug use (in that me paired with drug user is being responded to more rapidly 
than not me paired with drug user). 
For the other SC-IAT, the mean latency when good and drug user shared a response key 
was subtracted from the mean latency when bad and drug user shared a response key. This 
difference score was then divided by the standard deviation of all of the blended trials. Thus, 
higher scores on the SC-IAT represented a stronger association between good and drug user (in 
that good paired with drug user is being responded to more rapidly than bad paired with drug 
user).  
The interaction between these two SC-IATs was used to examine internalized stigma. 
Internalized stigma should be associated with higher numbers on the me/not me with drug user 
SC-IAT and lower numbers on the good/bad with drug user SC-IAT. That is, participants who 
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identify as a drug user (and thus are faster to associate me with drug user) while simultaneously 
indicating that drug users are bad (faster to associate drug users with bad) are those who have 
internalized the stigma. 
Results 
Table 1 provides a detailed description of the sample. The correlations between study 
variables can be found in Table 2. To the degree that participants internalized the stigma about 
their group (measured explicitly via the internalizing stigma scale of Cama et al., 2016), they felt 
less comfortable attending NSPs, had greater severity of dependence, and had more depressive 
symptoms. Thus, at the bivariate level, explicit internalized stigma is associated with poorer 
psychosocial functioning and healthcare/treatment access, but is unrelated to risk behaviors. The 
attitudes towards PWID scale used by Rivera et al. (2014) was correlated with the internalized 
stigma scale, but did not relate to any of the other study variables. Although unrelated to the 
primary purposes of this study, it is interesting to note that participants who had more depressive 
symptoms were more likely to binge on two or more drugs, had greater severity of dependence, 
and were less likely to share needles (possibly because they are spending more time alone).  
Regression analyses. Hierarchical multiple regression analyses were conducted for each 
of the outcome variables to determine whether implicit internalized stigma accounts for 
significant unique variance in risk behaviors, health care and treatment access, and psychosocial 
functioning. Attitudes towards PWID (as measured by Rivera et al, 2014) and explicit 
internalized stigma were entered in the first step of the model; the two SC-IATs were entered in 
the second step; and the interaction between the two SC-IATS (indicating implicit internalized 
stigma) was entered in the third step. The results for all analyses are reported in Table 3. These 
analyses revealed that implicit internalized stigma accounts for unique variance in needle sharing 
and treatment engagement.  
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Risk behaviors. Only the implicit measure of internalized stigma accounted for significant 
unique variance in needle sharing. To decompose this interaction it was plotted at one standard 
deviation above and below the mean (see Figure 2). Unexpectedly, participants were more likely 
to share needles and syringes if they identified as a drug user and thought drug users are good. 
That is, participants who internalized a positive view of being a drug user are more likely to share 
injecting equipment. None of the variables accounted for unique variance in whether participants 
used two or more drugs simultaneously (binge drug use) or whether participants were having 
unprotected sex (sexual risk taking). 
Health care and treatment access. As can be seen in Table 3, participants who implicitly 
identify as drug users (i.e., faster to associate me with drug user than not me with drug user) 
attempted treatment longer ago than those who do not implicitly identify as drug users. The 
implicit measure of internalized stigma also accounted for significant unique variance in how 
long ago participants had attempted treatment. To decompose this interaction it was plotted at one 
standard deviation above and below the mean (see Figure 3). Similar to the pattern with needle 
sharing, participants who identified as a drug user and thought drugs were good attempted 
treatment longer ago than other participants. Thus, it seems that participants who have 
internalized a positive view of being a drug user are less likely to pursue treatment.   
Consistent with the correlation results, only explicit internalizing stigma related to 
comfort in attending NSPs, such that participants who had internalized the stigma indicated less 
comfort attending NSPs.  
Psychosocial functioning. Consistent with the correlation results, only the explicit 
internalizing stigma measure related to participants’ mental health and severity of dependence. 
Specifically, participants who had internalized the stigma had more depressive symptoms over 
the past week and were more dependent on drugs. 
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Discussion 
PWID are widely stigmatized, being stereotyped as irresponsible, dangerous, and out of 
control (Smith et al., 2016). As a consequence they may come to internalize these stereotypes 
about themselves. Previous research demonstrates a variety of negative consequences when 
people from stigmatized groups internalize the stigma about their group (e.g., Livingston & 
Boyd, 2010). In this research we examined both psychological and behavioral consequences of 
implicit and explicit internalized stigma among PWID.  
Consistent with previous research, increased experiences of explicit internalized stigma 
was associated with less comfort in attending NSPs, greater depressive symptoms, and increased 
dependence on drugs. In contrast, attitudes towards PWID did not relate to these outcomes in the 
current study providing support for the findings of Corrigan et al. (2006), who note that people 
from stigmatized groups may believe the stereotypes associated with their group are true, but may 
nevertheless not internalize the stigma. Our explicit measure, adapted from the measure of 
internalized mental health stigma, taps endorsement of self-stigma rather than just endorsement of 
stereotypes (Boyd et al., 2014). Nonetheless, neither explicit measure related to risky behaviors. 
Data from the implicit measure revealed those who show internalized implicit positivity 
toward PWID – that is, they implicitly identified as a drug user and thought that drug users were 
good, were less likely to have recently engaged in drug treatment. This finding suggests that 
implicit positivity about their drug use equates to a reduced perceived need for drug treatment. 
Alternatively, those who feel implicitly positive about being a drug user may be managing their 
drug use better and thus are less likely to feel that their drug use negatively impacts them, 
explaining why they had lower treatment engagement. 
Unexpectedly, participants in this sample who showed internalized implicit positivity 
toward PWID were more likely to share injecting equipment. Such a relationship is surprising in 
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light of previous research showing that those who engage in risky practices such as sharing 
injecting equipment tend to feel particularly negative about themselves, and hence are less 
concerned about their health or causing themselves harm (Fraser and Treloar, 2006). Instead, this 
research suggests that at an implicit level increased sharing of injecting equipment is related to 
feeling positive about being a drug user. It is not uncommon to see discrepancies between explicit 
and implicit measures (e.g., Fazio and Olson, 2003; Wilson et al., 2002). Indeed, implicit 
associations sometimes predict current and future behavior better than consciously expressed 
beliefs and attitudes do (e.g., Nock et al., 2010; Wolff et al., 2015). Nonetheless, it is not clear 
why implicit positivity relates to greater likelihood of sharing needles.  
Policy Implications 
This research contributes to the small but growing literature that identifies the impact of 
internalized stigma on the health of PWID. These findings suggest that explicit aspects of 
internalized stigma act as a barrier to service access and are associated with increased depression, 
drug dependence, and severity of drug use. Greater dependence on drugs and poorer health 
outcomes result in more suffering for PWID, and pose an increased public health burden (e.g., 
increased risk of illness, overdose and death; possible engagement in crime to procure drugs). 
These effects may be exacerbated by less comfort in attending health services, which was also 
noted among those who report more internalized stigma. Health facilities such as NSPs serve not 
only as a place to obtain sterile injecting equipment but also as a means to access health 
information related to drug use. Some NSPs even provide brief psychosocial interventions and 
physical health checks as part of a comprehensive health service (Brener, Spooner, & Treloar, 
2010). Reduced engagement with drug treatment facilities is therefore likely to increase the 
public health burden of drug use. Health workers who see PWID should be made aware of the 
impact of internalized stigma. PWID report that stigma by others, which leads to internalized 
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stigma, commonly occurs in health care settings (Brener et al, 2017; Hopwood, Treloar & Bryant, 
2006). The current research highlights the need to develop strategies to reduce stigma to avoid 
poor health outcomes for PWID and reduce the associated public health costs. Service training 
for health care staff should specifically address the impact of internalized stigma on these 
important health outcomes. 
Limitations and future directions 
The most notable limitation of this research is the use of a cross-sectional design, which 
does not allow for the establishment of causality. It is possible that sharing needles and/or 
minimal treatment engagement leads to implicit positivity. It is also possible that sharing needles 
and implicit positivity are a function of a third, unmeasured variable. This causal uncertainty also 
applies to the explicit measures. Greater dependence on drugs, more depressive symptoms, and 
less comfort attending NSPs may lead to increased internalized stigma, or they may all be caused 
by a third factor. Longitudinal research would help determine the potential causal role of 
internalized stigma on these attitudinal and behavioral measures.  
Another limitation is the use of a single item to tap some of the constructs of interest, such 
as treatment engagement. Multiple item measures are preferable for psychometric reasons, but 
there is considerable evidence that single item measures are reliable and valid (e.g., Robins, 
Hendin, & Trzesniewski, 2001; Wanous, Reichers, Hudy, 1997). Given concerns about 
participant attentiveness and survey length, a single item measure was deemed appropriate to use. 
Future research would also benefit by including objective behavioral indicators of health 
care and treatment access, psychosocial functioning, and engagement in risky behaviors, rather 
than relying on self-report (which is subject to errors in recall and social desirability). 
Nonetheless, the measures included in this research are widely used and validated self-report 
indicators of their respective constructs.  
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The generalizeability of this research should also be considered. We focused exclusively 
on clients attending NSPs, and thus it is not clear whether this pattern of results would emerge 
among people who use other substances or are attending different health services. Additionally, 
we cannot rule out the possibility that clients who chose to participate differed systematically 
from those who did not. Staff at the center believe that clients who chose not to participate did so 
because they did not have the time, suggesting that self-selection is not a significant concern. 
Nonetheless, future research is required to assess the generalizability of these results.  
Concluding thoughts 
Findings of this study highlight the importance of research into internalized stigma 
especially with PWID. Internalized stigma relates to a range of negative outcomes among other 
stigmatized groups (e.g., people living with HIV). Our research suggests these results generalize 
to PWID, whereby those who internalized the stigma had higher depression, greater severity of 
dependence, and less comfort in attending NSPs. This research also highlights the significance of 
assessing both explicit and implicit internalized stigma as these are associated with different 
health behaviors and health outcomes for PWID. Finally, the findings of this study suggest that 
there is still much work to be done in order to develop a better conceptual understanding of the 
implications of internalized stigma, particularly implicit internalized stigma, and its relationship 
to health outcomes and risk practices for stigmatized groups.  
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Table 1: Characteristics of the sample 
N=115 N (%) 
Age M (SD) (Range) 42.18 (8.23) (22-58) 
Gender  
        Male 69 (60.5) 
        Female 45 (39.5) 
Aboriginal or Torres Strait Islander 30 (26.1) 
Sexuality  
       Heterosexual 104 (90.4) 
      Gay/Lesbian 2 (1.7) 
      Bisexual 6 (5.2) 
Highest level of education  
      Leaving school before year 12 80 (69.6) 
      Completing Year 12 10 (8.7) 
      Trade Certificate/TAFE 16 (13.9) 
      University degree 8 (7) 
Main source of income  
     Benefits 91 (80) 
     Full time/part time/casual/contract work 15 (13) 
     No money/no income 6 (2.6) 
Accommodation  
      Own house/flat 10 (8.7) 
      Rental house or flat/ boarding house/hostel 75 (65.2) 
      Parent’s place 11 (9.6) 
     Streets/homeless 10 (8.7) 
Drug Use  
Age of first injection M (SD) 18.68 (6.88) 
Frequency   
      More than 3 times a day 21 (18.6) 
      2-3 times a day 20 (17.7) 
     Once a day 17 (15) 
     Weekly  37 (32.6) 
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     I did not inject in the last two weeks 18 (15.9) 
Main drug of choice   
    Heroin 36 (37.9) 
    Other opiates 10 (10.5) 
    Meth/amphetamines 36 (37.9) 
    Methadone 11 (11.6) 
Binged on two or more drugs over an extended period  
    Never  22 (19.3) 
    Sometimes 54 (47.4) 
    Regularly 38 (33.3) 
How many of your friends inject?  
    None 6 (5.2) 
    A few 32 (27.8) 
    Some 19 (16.5) 
    Most  46 (40) 
    All 6 (5.2) 
Drug Treatment experiences  
Have you ever been in any professional treatment for drug use  
    Yes 93 (80.9) 
When were you last in treatment  
    Currently 36 (31.3) 
    Less than 1 year ago 18 (15.7) 
    1-5 years ago 13 (20) 
    More than 5 year sago 13 (11.3) 
    Can’t remember 3 (2.6) 
Did you complete your last treatment?  
    Yes 25 (21.7) 
    No 35 (30.4) 
    Currently on treatment 30 (26.1) 
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Table 2: Correlations between study variables 
Variable 1 2 3 4 5 6 7 8 9 10 11 
1   Implicit internalised stigma  -           
2   Explicit internalised stigma  -
.110 
-          
3   Attitudes towards PWID  -
.075 
.531*** -         
4   Risky needle sharing 
behaviour  
-
.175 
.067 .021 -        
5   Healthcare access  .059 -.209* -
.038 
.034 -       
6   Risky sexual behaviour  -
.117 
.151 .158 -
.037 
.175 -      
7   Psychsocial functioning  -
.138 
.295*** .147 -
.215* 
-
.116 
.209* -     
8   Severity of Dependence .062 .373*** .139 -
.080 
-
.054 
.130 .360*** -    
9   Binge drug use -
.006 
-.122 -
.109 
.037 .017 -.098 .244** .061 -   
10  Treatment engagement  .248* -.110 -
.131 
.031 -
.067 
-.124 -.030 -
.038 
.210   
11 Age .016 .039 .070 .137 .183 .333*** .080 .071 -
.210* 
-.011  
12 Gender -
.026 
.144 .037 -
.037 
-
.097 
-.050 .102 .035 -
.159 
-
.303** 
-
.055 
 
Note: All correlations use pairwise deletion. * p <. 05, **p < .01, ***p < .001 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
Table 3: Regression analysis depicting the relationships between internalized stigma and 
risk behaviors, health care and treatment access, and psychosocial functioning 
Needle sharing 
 Beta t p R
2
 ΔR2 
Explicit internalised stigma .036 .315 .754   
Attitudes towards PWID -.043 -.382 .703 .005 .005 
Implicit identification with drug users -.098 -1.014 .313   
Implicit attitude towards drugs -.154 -1.574 .119 .031 .026 
Implicit internalised stigma -.195 -2.019 .046 .067 .037* 
Treatment engagement   
 Beta t p R
2
 ΔR2 
Explicit internalised stigma -.038 -.313 .755   
Attitudes towards PWID -.028 -.232 .817 .019 .019 
Implicit identification with drug users .243 2.279 .025   
Implicit attitude towards drugs .051 .492 .624 .051 .032 
Implicit internalised stigma .297 2.836 .006 .132 .080** 
Comfort in attending NSP      
 Beta t p R
2
 ΔR2 
Explicit internalised stigma -.279 -2.480 .015   
Attitudes towards PWID .107 .964 .337 .051 .051 
Implicit identification with drug users .064 .672 .503   
Implicit attitude towards drugs -.078 -.815 .417 .060 .009 
Implicit internalised stigma .043 .449 .654 .061 .002 
Binge Use      
 Beta t p R
2
 ΔR2 
Explicit internalised stigma -.107 -.936 .352   
Attitudes towards PWID -.050 -.447 .656 .018  
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* p <. 05, **p < .01, ***p < .001 
 
Implicit identification with drug users .104 1.076 .284  .018 
Implicit attitude towards drugs -.043 -.438 .662 .030 .012 
Implicit internalised stigma -.008 -.083 .934 .030 .000 
Risky sexual behaviour      
 Beta t p R
2
 ΔR2 
Explicit internalised stigma .089 .797 .427   
Attitudes towards PWID .091 .823 .412 .031 .031 
Implicit identification with drug users -.106 -1.100 .274   
Implicit attitude towards drugs -.010 -.103 .918 .039 .008 
Implicit internalised stigma -.116 -1.210 .229 .052 .013 
Psychosocial functioning      
 Beta t p R
2
 ΔR2 
Explicit internalised stigma .294 2.678 .009   
Attitudes towards PWID -.004 -.035 .972 .087 .087** 
Implicit identification with drug users .071 .767 .445   
Implicit attitude towards drugs .036 .382 .703 .096 .009 
Implicit internalised stigma -.094 -1.016 .312 .105 .009 
Severity of Dependence      
 Beta t p R
2
 ΔR2 
Explicit internalised stigma .428 4.012 .000   
Attitudes towards PWID -.076 -.721 .473 .144 .144*** 
Implicit identification with drug users .023 .259 .796   
Implicit attitude towards drugs .014 .150 .881 .144 .000 
Implicit internalised stigma .108 1.194 .235 .155 .011 
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Figure 1: Example of the SC-IAT 
 
 
 
 
 
Figure 1: Illustration of sample screens and stimuli from the implicit association with drug users 
SC-IAT. The category labels are placed in the top right and left corners and participants must 
classify the words presented in the middle of the screen as quickly as possible. The categories 
good and drug user are paired together on the computer screen to the left. This pairing is then 
reversed on the computer screen to the right (drug user and bad are paired together). The implicit 
attitude is inferred by the relative ease with which the words stereotypically associated with drug 
users can be responded to on the good or bad response key. Participants who are faster to 
associate bad with drug user than good with drug user are implicitly indicating that drug users 
are bad.  
 
Good         Bad 
Drug User 
 
  Excellent 
Good          Bad 
                                   Drug User 
 
  Smashed 
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Figure 2: Internalized stigma and needle sharing
 
Negative implicit attitude   Positive implicit attitude
 
 
Figure 2: Needle sharing as a function of implicit identification with drugs and implicit attitudes 
towards drugs. Simple slopes are estimated at one standard deviation above and below the mean. 
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Figure 3: Internalized stigma and drug treatment engagement 
 
Negative implicit attitude   Positive implicit attitude 
 
 
Figure 3: Drug treatment engagement as a function of implicit identification with drugs and 
implicit attitudes towards drugs. Simple slopes are estimated at one standard deviation above and 
below the mean. 
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Highlights 
 Implicit and explicit internalized stigma among people who inject drugs is assessed. 
 Explicit internalized stigma is associated with poorer psychosocial functioning. 
 Explicit internalized stigma is associated with less comfort attending NSPs. 
 Implicit positivity is associated with needle sharing and treatment avoidance. 
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